Brandinium

Trademark search for:

AMRYT PHARMA

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2016-11-21 — Application filed
  • 2017-02-23 — Sn assigned for sect 66a appl from ib
  • 2017-02-27 — Application filed
  • 2017-02-28 — Assigned to examiner
  • 2017-03-01 — Assigned to examiner
  • 2017-03-03 — Final disposition recorded
  • 2017-03-03 — Application filed
  • 2017-03-04 — Office action issued
  • 2017-03-07 — Office action issued
  • 2017-03-07 — Office action issued
  • 2017-03-25 — Office action issued
  • 2017-09-07 — Office action issued
  • 2017-09-08 — Teas change of correspondence received
  • 2017-09-13 — Assigned to lie
  • 2017-09-15 — Teas/email correspondence entered
  • 2017-09-15 — Correspondence received in law office
  • 2017-10-12 — Office action issued
  • 2017-10-12 — Office action issued
  • 2017-10-12 — Office action issued
  • 2018-05-10 — Application abandoned
  • 2018-05-10 — Application abandoned
  • 2018-05-10 — Final status recorded
  • 2018-07-25 — Notification of possible opposition sent to ib
  • 2018-07-25 — Notification of possible opposition created, to be sent to ib
  • 2018-08-10 — Notification of possible opposition - processed by ib
  • 2019-05-10 — Final disposition recorded
  • 2019-05-10 — Final disposition recorded
  • 2019-05-31 — Final disposition recorded
  • 2020-07-09 — Change of name/address rec'd from ib
  • 2020-09-11 — Restriction of holder's right of disposal received
  • 2020-09-24 — Limitation from the ib examined, no action is needed
  • 2021-09-19 — Correction transaction received from ib
  • 2021-10-08 — Correction from the ib examined, no action is needed
  • 2022-01-07 — Change of name/address rec'd from ib
  • 2022-05-08 — Restriction of holder's right of disposal received
  • 2022-06-11 — Restriction of holder's right of disposal received
  • 2022-06-22 — Limitation from the ib examined, no action is needed
  • 2022-07-01 — Limitation from the ib examined, no action is needed
  • 2023-07-30 — Restriction of holder's right of disposal received
  • 2023-10-24 — Limitation from the ib examined, no action is needed

Owner Information

Amryt Pharmaceuticals DAC
IE

Correspondent

Best Rechtsanwälte
Hostatostr. 26
65929 Frankfurt am Main,
GERMANY

Filing Details

Filing Date:
2016-11-21
Status Date:
2018-05-10
Filing Year:
2016

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.